3D ...

Very nice line up. Nice balance. And rational :)

I think NOT needs a DE3 for $20 but it all depends on more assays (possibly for Eagle 1-3). Clearly, NOT also has numerous more anomalies to explore.

Remember, if NOT hits $20, it probably will look for some more PP money to continue an aggressive exploration program. Of course, this is subject to a "major" like CVRD making a bid for it. But I don't think this will happen until more exploration work is done.

Finally, given the greater database of knowledge gleaned from ongoing the ATEM and now VTEM work, there are strong possiblities that strikes from NOT and FWR-SPQ are in the near future (1-6 weeks).

From my humble perspective, your investment strategy looks sound.

Snug